We are monitoring the impact of COVID-19 on APAC Lidocaine Ointment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5337
Share on
Share on

Asia Pacific Lidocaine Ointment Market Research Report - Segmented By Formulation, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 5337
Pages: 145

Asia Pacific Lidocaine Ointment Market Size & Growth (2021 to 2026):

The Asia Pacific Lidocaine Ointment Market size was valued at USD 291.52 Million and is projected to reach USD 472.91 Million by 2026, to grow at a healthy CAGR of 10.16% from 2021 to 2026.

Lidocaine topical in ointment form reduces pain or discomfort caused by various conditions, namely eczema, sunburn, atopic dermatitis, insect bites, poison ivy, piles, minor cuts, and burns, etc. The growth of the APAC lidocaine ointment market is attributed to several favorable market parameters, including the rise in the prevalence of skin conditions and the growing population of elderly patients prone to more chronic health disorders such as hemorrhoids and periodontitis, among others. In addition, medical tourism is prevalent in APAC regions due to cheap healthcare costs, specialized doctors, and the availability of good medical facilities.

According to a 2018 report of statistics from the United Nations Population Fund, people aged 60 and over made up about 13.9% of the world's population that year. The report adds that the figure would increase by about 22% by 2050. Furthermore, with evolving pharmaceutical industries in the APAC region, the production of lidocaine ointment is significant and results in lower prices across the region. Successful production and distribution result in the broader reach of the products, which is expected to be a critical factor in the Asia-Pacific lidocaine ointment market.

Other fundamental factors contributing to the expansion of the market include the increasing incidence of dental caries, periodontics, and oral cancer in the region, high plastic/cosmetic surgeries rate, increasing soft tissue and laser surgeries are driving the market. The earliest estimate recorded by 1992 shows the high prevalence of periodontitis and poor periodontal health was estimated to be found in nearly 92% of residents aged 25 and over in the Kingdom of Saudi Arabia. The high prevalence of periodontitis in the African region follows clinical findings; the periodontitis prevalence was above 50%, especially in areas of Kenya and Tanzania during the year 2019.

Application of lidocaine ointment includes several side effects such as ulceration, drowsiness, confusion, tingling, vomiting, rigidity, and irregular heartbeat, especially when combined with epinephrine. Due to the large and over-expansion of pharmaceutical companies in the APAC regions, the pricing is not regulated. The presence of a vast production capacity has put pressure on the prices. Generics have captured most of the market, and the rise of counterfeit products has limited market growth.

This research report on the Asia Pacific Lidocaine Ointment Market segmented and sub-segmented into the following categories

By Formulation:

  • Internal Use
  • Topical Use

By Application:

  • Medical
  • Cosmetics

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, China lidocaine ointment market will account for a significant market share of 25% of the APAC lidocaine ointment market due to its large population, low production costs, and rapidly developing and expanding healthcare facilities. In 2019, China had a health expenditure of about 6.7% of the GDP, while in 2018, the numbers were at 6.5 %.

The increasing use of lidocaine ointment for veterinary, dental, and cosmetic surgeries is estimated to drive the future market, as China has increased healthcare awareness and excellent medical facilities. In addition, the significant unmet needs of populated countries such as Australia, China, and India are driving further growth of the lignocaine ointment market in the APAC regions.

The lidocaine ointment market is expected to be good in Bangladesh, Pakistan, Indonesia, and Thailand, mainly due to growing economic standards, higher unmet needs, faster healthcare facilities, and cheaper products. These factors are predicted to influence the market in these regions due to the low cost of raw materials and production rates. On the other hand, India is anticipated to grow reasonably due to less strict government regulations and an excellent medical tourism spot for foreigners.

KEY MARKET PLAYERS

Top Companies dominating the Asia Pacific Lidocaine Ointment Market Profiled in the Report are AstraZeneca Plc., Glenmark Pharmaceuticals, Teligent, Inc., Proficient Rx LP, ., Septodont Healthcare India Pvt. Ltd., Gemini Pharmaceuticals,  Amneal Pharmaceuticals LLC, Taro Pharmaceuticals U.S.A. Inc., Novocol Inc. and  Centura Pharmaceuticals, Inc.,

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Formulation     

      5.1.1 Introduction           

      5.1.2 Internal Use           

      5.1.3 Topical Use             

      5.1.4  Y-o-Y Growth Analysis, By Formulation      

      5.1.5  Market Attractiveness Analysis, By Formulation    

      5.1.6  Market Share Analysis, By Formulation     

                5.2 Application                 

      5.2.1 Introduction           

      5.2.2 Cosmetics

      5.2.3 Medical    

      5.2.4 Others      

      5.2.5 Y-o-Y Growth Analysis, By Application         

      5.2.6 Market Attractiveness Analysis, By Application       

      5.2.7 Market Share Analysis, By Application        

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Formulation

                      6.1.3.3 By Application

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Formulation

                      6.1.4.3 By Application

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Formulation

                      6.1.5.3 By Application

                6.2 China   

                6.3 India    

                6.4 Japan  

                6.5 South Korea     

                6.6 Australia       

                6.7 Rest of APAC               

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 AstraZeneca Plc.                       

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Centura Pharmaceuticals, Inc.  

                8.3 Amneal Pharmaceuticals LLC     

                8.4 Gemini Pharmaceuticals, Inc.    

                8.5 Glenmark Pharmaceuticals                  

                8.6 Novocol Inc.     

                8.7 Proficient Rx LP                         

                8.8 Septodont Healthcare India Pvt. Ltd.     

                8.9 Taro Pharmaceuticals U.S.A., Inc.                      

                8.10 Teligent, Inc.  

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  2. Asia Pacific Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  3. Asia Pacific Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  4. Asia Pacific Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  5. Asia Pacific Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  6. Asia Pacific Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  7. Asia Pacific Medical Market By Region, From 2021 to 2026 ( USD Million )
  8. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  9. Japan Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  10. Japan Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  11. China Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  12. China Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  13. India Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  14. India Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  15. Australia Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  16. Australia Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  17. South Korea Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  18. South Korea Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample